Genus plc (LON:GNS – Get Free Report) shares passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 1,818.83 ($23.55) and traded as high as GBX 1,970 ($25.50). Genus shares last traded at GBX 1,952 ($25.27), with a volume of 7,896,197 shares traded.
Analyst Ratings Changes
Separately, Shore Capital reaffirmed a “buy” rating on shares of Genus in a research note on Wednesday, December 11th.
Read Our Latest Analysis on Genus
Genus Price Performance
Genus (LON:GNS – Get Free Report) last issued its quarterly earnings data on Thursday, February 27th. The company reported GBX 39.80 ($0.52) EPS for the quarter. Genus had a net margin of 1.18% and a return on equity of 1.41%. As a group, equities analysts expect that Genus plc will post 70.9644323 EPS for the current fiscal year.
Insiders Place Their Bets
In other Genus news, insider Jorgen Kokke sold 19,967 shares of the company’s stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of GBX 1,731 ($22.41), for a total value of £345,628.77 ($447,473.81). Company insiders own 0.75% of the company’s stock.
About Genus
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.
Recommended Stories
- Five stocks we like better than Genus
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell
- 3 Healthcare Dividend Stocks to Buy
- Top 3 Beverage Stocks Pouring Out Profits
- Are Penny Stocks a Good Fit for Your Portfolio?
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.